Grifols SA ADR (NASDAQ: GRFS) kicked off on Tuesday, down -8.24% from the previous trading day, before settling in for the closing price of $9.22. Over the past 52 weeks, GRFS has traded in a range of $5.30-$12.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.28%. While this was happening, its average annual earnings per share was recorded 86.24%. With a float of $257.30 million, this company’s outstanding shares have now reached $257.44 million.
Let’s determine the extent of company efficiency that accounts for 23744 employees. In terms of profitability, gross margin is 38.33%, operating margin of 14.76%, and the pretax margin is 4.43%.
Grifols SA ADR (GRFS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Grifols SA ADR is 0.06%, while institutional ownership is 55.44%.
Grifols SA ADR (GRFS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.63 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 86.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 60.53% during the next five years compared to -37.97% drop over the previous five years of trading.
Grifols SA ADR (NASDAQ: GRFS) Trading Performance Indicators
Take a look at Grifols SA ADR’s (GRFS) current performance indicators. Last quarter, stock had a quick ratio of 0.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.25 and is forecasted to reach 0.99 in one year’s time.
Technical Analysis of Grifols SA ADR (GRFS)
Looking closely at Grifols SA ADR (NASDAQ: GRFS), its last 5-days average volume was 1.69 million, which is a drop from its year-to-date volume of 1.88 million. As of the previous 9 days, the stock’s Stochastic %D was 35.13%. Additionally, its Average True Range was 0.42.
During the past 100 days, Grifols SA ADR’s (GRFS) raw stochastic average was set at 59.89%, which indicates a significant increase from 11.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.59% in the past 14 days, which was higher than the 56.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.88, while its 200-day Moving Average is $7.75. However, in the short run, Grifols SA ADR’s stock first resistance to watch stands at $8.60. Second resistance stands at $8.75. The third major resistance level sits at $8.91. If the price goes on to break the first support level at $8.29, it is likely to go to the next support level at $8.13. Should the price break the second support level, the third support level stands at $7.98.
Grifols SA ADR (NASDAQ: GRFS) Key Stats
The company with the Market Capitalisation of 2.18 billion has total of 687,560K Shares Outstanding. Its annual sales at the moment are 7,135 M in contrast with the sum of 64,200 K annual income. Company’s last quarter sales were recorded 1,972 M and last quarter income was 56,840 K.
